A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-03-08

AUTHORS

A Palumbo, F Hauler, P Dziunycz, K Schwager, A Soltermann, F Pretto, C Alonso, G F Hofbauer, R W Boyle, D Neri

ABSTRACT

Background:The possibility of eradicating cancer by selective destruction of tumour blood vessels may represent an attractive therapeutic avenue, but most pharmaceutical agents investigated so far did not achieve complete cures and are not completely specific. Antibody conjugates now allow us to evaluate the impact of selective vascular shutdown on tumour viability and to study mechanisms of action.Methods:We synthesised a novel porphyrin-based photosensitiser suitable for conjugation to antibodies and assessed anticancer properties of its conjugate with L19, a clinical-stage human monoclonal antibody specific to the alternatively spliced EDB domain of fibronectin, a marker of tumour angiogenesis.Results:Here we show in two mouse model of cancer (F9 and A431) that L19 is capable of highly selective in vivo localisation around tumour blood vessels and that its conjugate with a photosensitiser allows selective disruption of tumour vasculature upon irradiation, leading to complete and long-lasting cancer eradication. Furthermore, depletion experiments revealed that natural killer cells are essential for the induction of long-lasting complete responses.Conclusions:These results reinforce the concept that vascular shutdown can induce a curative avalanche of tumour cell death. Immuno-photodynamic therapy may be particularly indicated for squamous cell carcinoma of the skin, which we show to be strongly positive for markers of angiogenesis. More... »

PAGES

1106-1115

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2011.78

DOI

http://dx.doi.org/10.1038/bjc.2011.78

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020004152

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21386847


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Squamous Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorescent Antibody Technique", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoconjugates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neovascularization, Pathologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Photochemotherapy", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.5801.c", 
          "name": [
            "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palumbo", 
        "givenName": "A", 
        "id": "sg:person.01120634634.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120634634.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.5801.c", 
          "name": [
            "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hauler", 
        "givenName": "F", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091, Zurich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.412004.3", 
          "name": [
            "Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091, Zurich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dziunycz", 
        "givenName": "P", 
        "id": "sg:person.0602123160.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602123160.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Philochem AG, c/o ETH Z\u00fcrich, Institute of Pharmaceutical Sciences, Wolfgang-Pauli-Strasse 10, HCI E520, 8093, Z\u00fcrich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.5801.c", 
          "name": [
            "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland", 
            "Philochem AG, c/o ETH Z\u00fcrich, Institute of Pharmaceutical Sciences, Wolfgang-Pauli-Strasse 10, HCI E520, 8093, Z\u00fcrich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schwager", 
        "givenName": "K", 
        "id": "sg:person.01073720454.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073720454.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.412004.3", 
          "name": [
            "Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soltermann", 
        "givenName": "A", 
        "id": "sg:person.0743264300.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743264300.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.5801.c", 
          "name": [
            "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pretto", 
        "givenName": "F", 
        "id": "sg:person.0624524014.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624524014.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemistry, University of Hull, Cottingham Road, Kingston-upon-Hull HU6 7RX, UK", 
          "id": "http://www.grid.ac/institutes/grid.9481.4", 
          "name": [
            "Department of Chemistry, University of Hull, Cottingham Road, Kingston-upon-Hull HU6 7RX, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alonso", 
        "givenName": "C", 
        "id": "sg:person.0663342455.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663342455.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091, Zurich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.412004.3", 
          "name": [
            "Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091, Zurich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hofbauer", 
        "givenName": "G F", 
        "id": "sg:person.010463412620.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010463412620.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemistry, University of Hull, Cottingham Road, Kingston-upon-Hull HU6 7RX, UK", 
          "id": "http://www.grid.ac/institutes/grid.9481.4", 
          "name": [
            "Department of Chemistry, University of Hull, Cottingham Road, Kingston-upon-Hull HU6 7RX, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boyle", 
        "givenName": "R W", 
        "id": "sg:person.01270352613.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270352613.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.5801.c", 
          "name": [
            "Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Z\u00fcrich, Wolfgang-Pauli-Strasse 10, 8093, Z\u00fcrich, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neri", 
        "givenName": "D", 
        "id": "sg:person.0771467351.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771467351.71"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrd1381", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006489607", 
          "https://doi.org/10.1038/nrd1381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1039/b708320c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037361966", 
          "https://doi.org/10.1039/b708320c"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/6179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035393625", 
          "https://doi.org/10.1038/6179"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0603-653", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010143012", 
          "https://doi.org/10.1038/nm0603-653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt0302-264", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022798368", 
          "https://doi.org/10.1038/nbt0302-264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035446044", 
          "https://doi.org/10.1038/sj.bjc.6603694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2009.52", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030217783", 
          "https://doi.org/10.1038/nrclinonc.2009.52"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022080605", 
          "https://doi.org/10.1038/nrc1627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603969", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042962854", 
          "https://doi.org/10.1038/sj.bjc.6603969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1894", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051508795", 
          "https://doi.org/10.1038/nrc1894"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-03-08", 
    "datePublishedReg": "2011-03-08", 
    "description": "Background:The possibility of eradicating cancer by selective destruction of tumour blood vessels may represent an attractive therapeutic avenue, but most pharmaceutical agents investigated so far did not achieve complete cures and are not completely specific. Antibody conjugates now allow us to evaluate the impact of selective vascular shutdown on tumour viability and to study mechanisms of action.Methods:We synthesised a novel porphyrin-based photosensitiser suitable for conjugation to antibodies and assessed anticancer properties of its conjugate with L19, a clinical-stage human monoclonal antibody specific to the alternatively spliced EDB domain of fibronectin, a marker of tumour angiogenesis.Results:Here we show in two mouse model of cancer (F9 and A431) that L19 is capable of highly selective in vivo localisation around tumour blood vessels and that its conjugate with a photosensitiser allows selective disruption of tumour vasculature upon irradiation, leading to complete and long-lasting cancer eradication. Furthermore, depletion experiments revealed that natural killer cells are essential for the induction of long-lasting complete responses.Conclusions:These results reinforce the concept that vascular shutdown can induce a curative avalanche of tumour cell death. Immuno-photodynamic therapy may be particularly indicated for squamous cell carcinoma of the skin, which we show to be strongly positive for markers of angiogenesis.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bjc.2011.78", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5215906", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "104"
      }
    ], 
    "keywords": [
      "tumor blood vessels", 
      "blood vessels", 
      "vascular shutdown", 
      "natural killer cells", 
      "squamous cell carcinoma", 
      "attractive therapeutic avenue", 
      "markers of angiogenesis", 
      "human monoclonal antibody", 
      "mechanism of action", 
      "selective disruption", 
      "tumor cell death", 
      "complete response", 
      "killer cells", 
      "cell carcinoma", 
      "complete cure", 
      "mouse model", 
      "tumor viability", 
      "therapeutic avenues", 
      "tumor vasculature", 
      "tumor angiogenesis", 
      "cancer eradication", 
      "complete eradication", 
      "monoclonal antibodies", 
      "selective destruction", 
      "selective vascular shutdown", 
      "EDB domain", 
      "most pharmaceutical agents", 
      "pharmaceutical agents", 
      "antibodies", 
      "depletion experiments", 
      "anticancer properties", 
      "cancer", 
      "antibody conjugates", 
      "cell death", 
      "vivo localisation", 
      "angiogenesis", 
      "eradication", 
      "vessels", 
      "markers", 
      "conjugates", 
      "carcinoma", 
      "therapy", 
      "tumors", 
      "disruption", 
      "vasculature", 
      "death", 
      "cure", 
      "skin", 
      "photosensitiser", 
      "induction", 
      "fibronectin", 
      "cells", 
      "agents", 
      "response", 
      "L19", 
      "destruction", 
      "viability", 
      "action", 
      "localisation", 
      "mechanism", 
      "conjugation", 
      "impact", 
      "irradiation", 
      "avenues", 
      "results", 
      "possibility", 
      "model", 
      "domain", 
      "shutdown", 
      "experiments", 
      "concept", 
      "properties", 
      "avalanches"
    ], 
    "name": "A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels", 
    "pagination": "1106-1115", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020004152"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2011.78"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21386847"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2011.78", 
      "https://app.dimensions.ai/details/publication/pub.1020004152"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_550.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bjc.2011.78"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.78'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.78'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.78'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.78'


 

This table displays all metadata directly associated to this object as RDF triples.

297 TRIPLES      22 PREDICATES      121 URIs      102 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2011.78 schema:about N1c5254d0169a4a2b9c12e2ec7271797b
2 N3753d923092e4f6fbe7ff26a27ef5809
3 N73ff2c9856154e98a182641bac1b065f
4 N9700fa14fc0b4a99a7b45a3bd65243d5
5 N98c76bc824d7465c8d0d97218c543fc7
6 N996e1f0962b749c4a12bf66288b7ac0c
7 Na1770f5d37d04446b445dfdc70054cc5
8 Nbeaefe96a53043daa5ba64801d261770
9 Ncda33a954fc84b3fa2c41e28d2470154
10 Ne3e8aa7c7ede410b939712aaa5731e96
11 Nf5f44d61aaa3428fa747fab6520becd7
12 anzsrc-for:11
13 anzsrc-for:1107
14 anzsrc-for:1112
15 schema:author Nae7f077795524a2e932552078548c2de
16 schema:citation sg:pub.10.1038/6179
17 sg:pub.10.1038/nbt0302-264
18 sg:pub.10.1038/nm0603-653
19 sg:pub.10.1038/nrc1627
20 sg:pub.10.1038/nrc1894
21 sg:pub.10.1038/nrclinonc.2009.52
22 sg:pub.10.1038/nrd1381
23 sg:pub.10.1038/sj.bjc.6603694
24 sg:pub.10.1038/sj.bjc.6603969
25 sg:pub.10.1039/b708320c
26 schema:datePublished 2011-03-08
27 schema:datePublishedReg 2011-03-08
28 schema:description Background:The possibility of eradicating cancer by selective destruction of tumour blood vessels may represent an attractive therapeutic avenue, but most pharmaceutical agents investigated so far did not achieve complete cures and are not completely specific. Antibody conjugates now allow us to evaluate the impact of selective vascular shutdown on tumour viability and to study mechanisms of action.Methods:We synthesised a novel porphyrin-based photosensitiser suitable for conjugation to antibodies and assessed anticancer properties of its conjugate with L19, a clinical-stage human monoclonal antibody specific to the alternatively spliced EDB domain of fibronectin, a marker of tumour angiogenesis.Results:Here we show in two mouse model of cancer (F9 and A431) that L19 is capable of highly selective in vivo localisation around tumour blood vessels and that its conjugate with a photosensitiser allows selective disruption of tumour vasculature upon irradiation, leading to complete and long-lasting cancer eradication. Furthermore, depletion experiments revealed that natural killer cells are essential for the induction of long-lasting complete responses.Conclusions:These results reinforce the concept that vascular shutdown can induce a curative avalanche of tumour cell death. Immuno-photodynamic therapy may be particularly indicated for squamous cell carcinoma of the skin, which we show to be strongly positive for markers of angiogenesis.
29 schema:genre article
30 schema:inLanguage en
31 schema:isAccessibleForFree true
32 schema:isPartOf N768e14a4fdbc440fb46185cb891c1741
33 Ne901afa7441349718ab55d35e2e73fb7
34 sg:journal.1017082
35 schema:keywords EDB domain
36 L19
37 action
38 agents
39 angiogenesis
40 antibodies
41 antibody conjugates
42 anticancer properties
43 attractive therapeutic avenue
44 avalanches
45 avenues
46 blood vessels
47 cancer
48 cancer eradication
49 carcinoma
50 cell carcinoma
51 cell death
52 cells
53 complete cure
54 complete eradication
55 complete response
56 concept
57 conjugates
58 conjugation
59 cure
60 death
61 depletion experiments
62 destruction
63 disruption
64 domain
65 eradication
66 experiments
67 fibronectin
68 human monoclonal antibody
69 impact
70 induction
71 irradiation
72 killer cells
73 localisation
74 markers
75 markers of angiogenesis
76 mechanism
77 mechanism of action
78 model
79 monoclonal antibodies
80 most pharmaceutical agents
81 mouse model
82 natural killer cells
83 pharmaceutical agents
84 photosensitiser
85 possibility
86 properties
87 response
88 results
89 selective destruction
90 selective disruption
91 selective vascular shutdown
92 shutdown
93 skin
94 squamous cell carcinoma
95 therapeutic avenues
96 therapy
97 tumor angiogenesis
98 tumor blood vessels
99 tumor cell death
100 tumor vasculature
101 tumor viability
102 tumors
103 vascular shutdown
104 vasculature
105 vessels
106 viability
107 vivo localisation
108 schema:name A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels
109 schema:pagination 1106-1115
110 schema:productId N7001852a812f42b7bb1a1c518d85afbb
111 N7b6a3e84dd244e169ecb5310485d5c6a
112 Nbe8a95b66b724f56b64efcdd6bba9beb
113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020004152
114 https://doi.org/10.1038/bjc.2011.78
115 schema:sdDatePublished 2022-05-20T07:27
116 schema:sdLicense https://scigraph.springernature.com/explorer/license/
117 schema:sdPublisher N62a14bd986fa42a9825213a84824e1ab
118 schema:url https://doi.org/10.1038/bjc.2011.78
119 sgo:license sg:explorer/license/
120 sgo:sdDataset articles
121 rdf:type schema:ScholarlyArticle
122 N104f351769d548ab86b69adbc72a8492 rdf:first sg:person.010463412620.81
123 rdf:rest Ne441ef90094d479fb45fc4c8622d5fda
124 N1c5254d0169a4a2b9c12e2ec7271797b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Humans
126 rdf:type schema:DefinedTerm
127 N3753d923092e4f6fbe7ff26a27ef5809 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Neoplasms, Experimental
129 rdf:type schema:DefinedTerm
130 N47b7d351b7a04cd89ac8610da1a4ae0f rdf:first N9a5486ad4c52455799420a3ca4840a5a
131 rdf:rest N8273460dda7b4574b39584852e1c3daa
132 N62a14bd986fa42a9825213a84824e1ab schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 N6751ed88964a454d821689c84a49cce2 rdf:first sg:person.0663342455.10
135 rdf:rest N104f351769d548ab86b69adbc72a8492
136 N7001852a812f42b7bb1a1c518d85afbb schema:name pubmed_id
137 schema:value 21386847
138 rdf:type schema:PropertyValue
139 N73ff2c9856154e98a182641bac1b065f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Animals
141 rdf:type schema:DefinedTerm
142 N768e14a4fdbc440fb46185cb891c1741 schema:issueNumber 7
143 rdf:type schema:PublicationIssue
144 N7b6a3e84dd244e169ecb5310485d5c6a schema:name dimensions_id
145 schema:value pub.1020004152
146 rdf:type schema:PropertyValue
147 N8273460dda7b4574b39584852e1c3daa rdf:first sg:person.0602123160.80
148 rdf:rest Nb9ecf79442c2448cb8e749a8808eb9e4
149 N9700fa14fc0b4a99a7b45a3bd65243d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Killer Cells, Natural
151 rdf:type schema:DefinedTerm
152 N98c76bc824d7465c8d0d97218c543fc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Carcinoma, Squamous Cell
154 rdf:type schema:DefinedTerm
155 N996e1f0962b749c4a12bf66288b7ac0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Immunoconjugates
157 rdf:type schema:DefinedTerm
158 N9a3cc538e8e046dda0afc57277b32da1 rdf:first sg:person.0771467351.71
159 rdf:rest rdf:nil
160 N9a5486ad4c52455799420a3ca4840a5a schema:affiliation grid-institutes:grid.5801.c
161 schema:familyName Hauler
162 schema:givenName F
163 rdf:type schema:Person
164 Na1770f5d37d04446b445dfdc70054cc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Fluorescent Antibody Technique
166 rdf:type schema:DefinedTerm
167 Nae7f077795524a2e932552078548c2de rdf:first sg:person.01120634634.15
168 rdf:rest N47b7d351b7a04cd89ac8610da1a4ae0f
169 Nb9ecf79442c2448cb8e749a8808eb9e4 rdf:first sg:person.01073720454.31
170 rdf:rest Nfd3c43a8411c4425848947f25af644bf
171 Nbe8a95b66b724f56b64efcdd6bba9beb schema:name doi
172 schema:value 10.1038/bjc.2011.78
173 rdf:type schema:PropertyValue
174 Nbeaefe96a53043daa5ba64801d261770 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Mice, Inbred BALB C
176 rdf:type schema:DefinedTerm
177 Ncda33a954fc84b3fa2c41e28d2470154 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Photochemotherapy
179 rdf:type schema:DefinedTerm
180 Ne3e8aa7c7ede410b939712aaa5731e96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Neovascularization, Pathologic
182 rdf:type schema:DefinedTerm
183 Ne441ef90094d479fb45fc4c8622d5fda rdf:first sg:person.01270352613.45
184 rdf:rest N9a3cc538e8e046dda0afc57277b32da1
185 Ne901afa7441349718ab55d35e2e73fb7 schema:volumeNumber 104
186 rdf:type schema:PublicationVolume
187 Nf5801cacccf8473bb35adfa3b1f1625d rdf:first sg:person.0624524014.78
188 rdf:rest N6751ed88964a454d821689c84a49cce2
189 Nf5f44d61aaa3428fa747fab6520becd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Mice
191 rdf:type schema:DefinedTerm
192 Nfd3c43a8411c4425848947f25af644bf rdf:first sg:person.0743264300.10
193 rdf:rest Nf5801cacccf8473bb35adfa3b1f1625d
194 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
195 schema:name Medical and Health Sciences
196 rdf:type schema:DefinedTerm
197 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
198 schema:name Immunology
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
201 schema:name Oncology and Carcinogenesis
202 rdf:type schema:DefinedTerm
203 sg:grant.5215906 http://pending.schema.org/fundedItem sg:pub.10.1038/bjc.2011.78
204 rdf:type schema:MonetaryGrant
205 sg:journal.1017082 schema:issn 0007-0920
206 1532-1827
207 schema:name British Journal of Cancer
208 schema:publisher Springer Nature
209 rdf:type schema:Periodical
210 sg:person.010463412620.81 schema:affiliation grid-institutes:grid.412004.3
211 schema:familyName Hofbauer
212 schema:givenName G F
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010463412620.81
214 rdf:type schema:Person
215 sg:person.01073720454.31 schema:affiliation grid-institutes:grid.5801.c
216 schema:familyName Schwager
217 schema:givenName K
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073720454.31
219 rdf:type schema:Person
220 sg:person.01120634634.15 schema:affiliation grid-institutes:grid.5801.c
221 schema:familyName Palumbo
222 schema:givenName A
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120634634.15
224 rdf:type schema:Person
225 sg:person.01270352613.45 schema:affiliation grid-institutes:grid.9481.4
226 schema:familyName Boyle
227 schema:givenName R W
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270352613.45
229 rdf:type schema:Person
230 sg:person.0602123160.80 schema:affiliation grid-institutes:grid.412004.3
231 schema:familyName Dziunycz
232 schema:givenName P
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602123160.80
234 rdf:type schema:Person
235 sg:person.0624524014.78 schema:affiliation grid-institutes:grid.5801.c
236 schema:familyName Pretto
237 schema:givenName F
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624524014.78
239 rdf:type schema:Person
240 sg:person.0663342455.10 schema:affiliation grid-institutes:grid.9481.4
241 schema:familyName Alonso
242 schema:givenName C
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663342455.10
244 rdf:type schema:Person
245 sg:person.0743264300.10 schema:affiliation grid-institutes:grid.412004.3
246 schema:familyName Soltermann
247 schema:givenName A
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743264300.10
249 rdf:type schema:Person
250 sg:person.0771467351.71 schema:affiliation grid-institutes:grid.5801.c
251 schema:familyName Neri
252 schema:givenName D
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771467351.71
254 rdf:type schema:Person
255 sg:pub.10.1038/6179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035393625
256 https://doi.org/10.1038/6179
257 rdf:type schema:CreativeWork
258 sg:pub.10.1038/nbt0302-264 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022798368
259 https://doi.org/10.1038/nbt0302-264
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/nm0603-653 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010143012
262 https://doi.org/10.1038/nm0603-653
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/nrc1627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022080605
265 https://doi.org/10.1038/nrc1627
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/nrc1894 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051508795
268 https://doi.org/10.1038/nrc1894
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/nrclinonc.2009.52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030217783
271 https://doi.org/10.1038/nrclinonc.2009.52
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/nrd1381 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006489607
274 https://doi.org/10.1038/nrd1381
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/sj.bjc.6603694 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035446044
277 https://doi.org/10.1038/sj.bjc.6603694
278 rdf:type schema:CreativeWork
279 sg:pub.10.1038/sj.bjc.6603969 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042962854
280 https://doi.org/10.1038/sj.bjc.6603969
281 rdf:type schema:CreativeWork
282 sg:pub.10.1039/b708320c schema:sameAs https://app.dimensions.ai/details/publication/pub.1037361966
283 https://doi.org/10.1039/b708320c
284 rdf:type schema:CreativeWork
285 grid-institutes:grid.412004.3 schema:alternateName Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091, Zurich, Switzerland
286 Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland
287 schema:name Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091, Zurich, Switzerland
288 Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland
289 rdf:type schema:Organization
290 grid-institutes:grid.5801.c schema:alternateName Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Wolfgang-Pauli-Strasse 10, 8093, Zürich, Switzerland
291 Philochem AG, c/o ETH Zürich, Institute of Pharmaceutical Sciences, Wolfgang-Pauli-Strasse 10, HCI E520, 8093, Zürich, Switzerland
292 schema:name Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Wolfgang-Pauli-Strasse 10, 8093, Zürich, Switzerland
293 Philochem AG, c/o ETH Zürich, Institute of Pharmaceutical Sciences, Wolfgang-Pauli-Strasse 10, HCI E520, 8093, Zürich, Switzerland
294 rdf:type schema:Organization
295 grid-institutes:grid.9481.4 schema:alternateName Department of Chemistry, University of Hull, Cottingham Road, Kingston-upon-Hull HU6 7RX, UK
296 schema:name Department of Chemistry, University of Hull, Cottingham Road, Kingston-upon-Hull HU6 7RX, UK
297 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...